Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
AVEO PHARMACEUTICALS, INC.
| Metric | AVEO PHARMACEUTICALS, INC. Healthcare |
|---|---|
| Quality Score | 22 / 100 |
| Revenue (latest) | $2M |
| Net income (latest) | −$22M |
| Operating margin | −995.6% |
| Net margin | −1152.2% |
| Return on equity | −48.2% |
| Return on assets | −21.0% |
| Return on capital (ROCE) | −22.1% |
| Debt / equity | 1.30× |
| Revenue growth (YoY) | −68.1% |
| Altman Z″ (distress) | -15.93 |
| Accruals / assets | 33.4% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.